title: Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
abstract: Phospholipases A(2) are enzymes responsible for the hydrolysis of membrane phospholipids that release arachidonic acid, which serves as substrate for pro-inflammatory mediators, such as prostaglandins and leucotriens. The design of specific inhibitors for PLA(2) might help in the development of new anti-inflammatory drugs. Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and aristolochic acid, are able to inhibit PLA(2) from different sources. Herein, we have studied the kinetic behavior and the capacity of inhibiting edema formation induced by PLA(2) of five different polyhydroxy phenolic compounds (two phenolic derivatives and three acetophenone hydroxylated derivatives) extracted from the venom of Crotalus adamanteus. The results showed that compounds 1,3-dihydroxy benzene, 1,3,5-trihydroxy benzene and 2,4,6-trihydroxy acetophenone were the most efficient in the inhibition of the enzymatic activity and edema induction by PLA(2). It was also verified that the number of hydroxyls in each molecule is not a limiting factor for the inhibition capacity of these compounds. Molecular modeling studies indicated that the most active compounds are linked to the amino acid Asp 49 and that they destabilize the coordination of the calcium atom, which is essential to the catalytic activity. The study of potential surfaces showed that there are conditions in which the potential values must be adequate for enzyme complex formation with polyhydroxy phenolic compounds. When the potential over the hydroxyl surfaces is very high, formation of stable complexes does not occur and the enzyme does not act intensely. These results might be helpful in the design of a drug that specifically inhibits PLA(2).
authors.affiliation: Depto de Química, ICE, Universidade Federal do Amazonas - UFAM, 69077-000 Manaus, AM, Brazil. biomol2@hotmail.com
authors.forename: S L
authors.initials: SL
authors.lastname: da Silva
authors.forename: A K
authors.initials: AK
authors.lastname: Calgarotto
authors.forename: V
authors.initials: V
authors.lastname: Maso
authors.forename: D C S
authors.initials: DC
authors.lastname: Damico
authors.forename: P
authors.initials: P
authors.lastname: Baldasso
authors.forename: C L
authors.initials: CL
authors.lastname: Veber
authors.forename: J A F P
authors.initials: JA
authors.lastname: Villar
authors.forename: A R M
authors.initials: AR
authors.lastname: Oliveira
authors.forename: M
authors.initials: M
authors.lastname: Comar
authors.forename: K M T
authors.initials: KM
authors.lastname: Oliveira
authors.forename: S
authors.initials: S
authors.lastname: Marangoni
mesh_terms: D000818:Animals; D003435:Crotalid Venoms / Q000737:chemistry*; D015195:Drug Design; D004487:Edema / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000302:isolation & purification; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D010636:Phenols / Q000302:isolation & purification* / Q000494:pharmacology; D064801:Phospholipase A2 Inhibitors
chemical_list: D003435:Crotalid Venoms; D004791:Enzyme Inhibitors; D010636:Phenols; D064801:Phospholipase A2 Inhibitors